windows v 8 5 (STATA Corporation)
STATA Corporation is a verified supplier 
99
Structured Review
STATA Corporation
windows v 8 5
Windows V 8 5, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 9327 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/windows+v+8+5/STATA+8%2E0/pmc03660274-101-11-14
Average 99 stars, based on 9327 article reviews
Windows V 8 5, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 9327 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/windows+v+8+5/STATA+8%2E0/pmc03660274-101-11-14
Average 99 stars, based on 9327 article reviews
windows v 8 5 - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
other:Article Title: Serum hepcidin: indication of its role as an “acute phase” marker in febrile children Article Snippet: All statistical analyses and data management were performed using STATA for Article Title: Clinical and laboratory indices of severe renal lesions in children with febrile urinary tract infection. Article Snippet: This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record.. Please cite this article as doi: 10.1111/apa.12706 This article is protected by copyright.. All rights reserved. Article Title: Fever duration during treated urinary tract infections and development of permanent renal lesions. Article Snippet: To cite: Karavanaki K, Koufadaki AM, Soldatou A, et al. Arch Dis Child Epub ahead of print: [please include Day Month Year]. doi:10.1136/ archdischild-2017-314576 Second Department of Pediatrics, University of Athens, "P&A Kyriakou" Children’s Hospital, Athens, Greece Second Department of Pediatrics, University of Athens, "P&A Kyriakou" Children’s Hospital, Athens, Greece Second Department of Pediatrics, University of Athens, "P&A Kyriakou" Children’s Hospital, Athens, Greece Second Department of Pediatrics, University of Athens, "P&A Kyriakou" Children’s Hospital, Athens, Greece Second Department of Pediatrics, "Aghia Sophia" Children’s Hospital, Athens, Greece Second Department of Pediatrics, University of Athens, "P&A Kyriakou" Childrens’ Hospital, Athens, Greece Second Department of Pediatrics, "Aghia Sophia" Children’s Hospital, Athens, Greece Department of Nephrology, "P&A Kyriakou" Children’s Hospital, Athens, Greece Article Title: Reproducibility of vibration perception threshold values in children and adolescents with type 1 diabetes mellitus and associated factors. Article Snippet: Aims: To define the reproducibility of vibration perception thresholds (VPTs) and the possible associated factors, as an early index of peripheral diabetic neuropathy (PDN) in type 1 diabetes mellitus (T1DM) children and adolescents.. Methods: A single examiner studied 118 T1DM subjects (aged 13.5 ± 3.4 years) and 79 controls (aged 12.0 ± 3.07 years).. Glycaemic control was assessed with HbA1c levels. Article Title: Quantiferon-Cytomegalovirus assay: A potentially useful tool in the evaluation of CMV-specific CD8+ T-cell reconstitution in pediatric hematopoietic stem cell transplant patients. Article Snippet: Allogeneic HSCT is a lifesaving procedure for children suffering from malignant and nonmalignant diseases.. Due to impaired Tcell reconstitution and immunosuppressive therapy following HSCT, pediatric patients are at high risk of human CMV reactivation, an infection associated with considerable morbidity and mortality.. Indeed not only can CMV infection cause severe and multiorgan disease (retinitis, gastroenteritis, encephalitis, hepatitis, pneumonitis, myocarditis), but it is also associated with the development of bacterial or fungal infections, graft rejection, or GVHD.1,2 Among these patients, regular virological surveillance, prophylactic, and preemptive antiviral therapies have effectively reduced Accepted: 6 April 2018 Article Title: Weight gain in children on oxcarbazepine monotherapy. Article Snippet: Background: Studies of the effect of oxcarbazepine (OXC) on body growth of children with epilepsy are rare and their results are controversial.. To the contrary, many studies have shown significant weight gain following valproate (VPA) treatment.. Purpose: To prospectively evaluate the effect of OXC monotherapy on growth patterns of children with epilepsy and compare it with the effect of VPA monotherapy. |